Lanzamiento Enero 2027

Ensayo controlado aleatorizado2022Financiación no declarada

Comparative randomized trial study about the efficacy of photobiomodulation and curcumin antimicrobial photodynamic therapy as a coadjuvant treatment of oral mucositis in oncologic patients: antimicrobial, analgesic, and degree alteration effect

de Cássia Dias Viana Andrade R, Azevedo Reis T, Rosa LP, de Oliveira Santos GP, da CristinaSilva F

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 21 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2022-05-24 · Support Care Cancer · vol. 30 · número 9 · págs. 7365–7371
Editorial
Springer Science+Business Media
Citado
23 citas · más que el 92% de estudios similares · 2.7× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
24 trabajos
Acceso
De pago
Áreas de investigación
Oral health in cancer treatment · Oral Health Pathology and Treatment · Photodynamic Therapy Research Studies
Palabras clave
oral mucositis, low-level laser therapy, antimicrobial photodynamic therapy, curcumin, blue LEDs, Candida, chemotherapy-induced mucositis, radiotherapy-induced mucositis, analgesia, nystatin, photosensitizers
MeSH
humans, stomatitis, curcumin, analgesics, anti-infective agents, anti-bacterial agents, photochemotherapy, adolescent, mucositis

5 autores

  • Rita de Cássia Dias Viana Andrade🇧🇷Universidade Cruzeiro do Sul
  • Thaís Azevedo Reis🇧🇷 · autor de correspondenciaUniversidade Federal da Bahia
  • Luciano Pereira Rosa🇧🇷Universidade Federal da Bahia
  • Gabriel Pinto de Oliveira Santos🇧🇷Universidade Federal da Bahia
  • Francine da CristinaSilva🇧🇷Universidade Federal da Bahia

Resumen

El texto original del estudio, en el idioma en que se publicó.

Introduction

As conventional treatments currently available for mucositis are not considerably effective, there is a need to implement an adjuvant protocol for the treatment of oral mucositis in patients undergoing radiotherapy and chemotherapy.

Purpose

To evaluate the effect of photobiomodulation (PBM) and antimicrobial photodynamic therapy (aPDT) mediated by curcumin and blue LED as an adjunct treatment of oral mucositis for oncology patients using chemotherapy and/or radiotherapy.

Methods

Clinical, randomized study, in a single location, in an oncology service of a general hospital, with a total of 30 patients (over 18 years old) with stable oral mucosa lesions in the process of chemotherapy and/or radiotherapy. The patients were divided into 3 groups: control group (treated with nystatin), PBM group (treated with low-level laser therapy), and the aPDT group (treated with 450-nm blue LED and curcumin photosensitizer).

Results

The results showed, by means of intra-group comparisons, that the two experimental treatments promoted yeast reduction of the genus Candida in the last two evaluations (21 days and 30 days), but not in the first two evaluations (7 days and 14 days). The intra-group comparisons showed that the control and aPDT group showed a significant difference in the degree of mucositis over the four evaluations performed, with the results pointing out that the mucositis worsened in the control group from the 14th day, while reduced in the aPDT group from the 21st day of treatment.

Conclusion

A reduction in the degree of mucositis and pain score was observed in the PBM and aPDT groups, with the aPDT group standing out when presenting early clinical improvement in relation to the PBM group and the control group, thus emphasizing its effectiveness within the desired aspects. Regarding the antimicrobial effect, aPDT showed a greater reduction of yeasts of the genus Candida in the tested parameters.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.